Treatment of Postmastectomy Pain With Ambulatory Continuous Paravertebral Nerve Blocks
Authors:
- 1 January 2014
- journal article
- research article
- Published by BMJ in Regional Anesthesia & Pain Medicine
- Vol. 39 (2) , 89-96
Abstract
Background We aimed to determine with this randomized, triple-masked, placebo-controlled study if benefits are afforded by adding a multiple-day, ambulatory, continuous ropivacaine paravertebral nerve block to a single-injection ropivacaine paravertebral block after mastectomy. Methods Preoperatively, 60 subjects undergoing unilateral (n = 24) or bilateral (n = 36) mastectomy received either unilateral or bilateral paravertebral perineural catheter(s), respectively, inserted between the third and fourth thoracic transverse process(es). All subjects received an initial bolus of ropivacaine 0.5% (15 mL) via the catheter(s). Subjects were randomized to receive either perineural ropivacaine 0.4% or normal saline using portable infusion pump(s) [5 mL/h basal; 300 mL reservoir(s)]. Subjects remained hospitalized for at least 1 night and were subsequently discharged home where the catheter(s) were removed on postoperative day (POD) 3. Subjects were contacted by telephone on PODs 1, 4, 8, and 28. The primary end point was average pain (scale, 0–10) queried on POD 1. Results Average pain queried on POD 1 for subjects receiving perineural ropivacaine (n = 30) was a median (interquartile) of 2 (0–3), compared with 4 (1–5) for subjects receiving saline (n = 30; 95% confidence interval difference in medians, −4.0 to −0.3; P = 0.021]. During this same period, subjects receiving ropivacaine experienced a lower severity of breakthrough pain (5 [3–6] vs 7 [5–8]; P = 0.046) as well. As a result, subjects receiving perineural ropivacaine experienced less pain-induced physical and emotional dysfunction, as measured with the Brief Pain Inventory (lower score = less dysfunction): 14 (4–37) versus 57 (8–67) for subjects receiving perineural saline (P = 0.012). For the subscale that measures the degree of interference of pain on 7 domains, such as general activity and relationships, subjects receiving perineural saline reported a median score 10 times higher (more dysfunction) than those receiving ropivacaine (3 [0–24] vs 33 [0–44]; P = 0.035). In contrast, after infusion discontinuation, there were no statistically significant differences detected between treatment groups. Conclusions After mastectomy, adding a multiple-day, ambulatory, continuous ropivacaine infusion to a single-injection ropivacaine paravertebral nerve block results in improved analgesia and less functional deficit during the infusion. However, no benefits were identified after infusion discontinuation.Keywords
This publication has 43 references indexed in Scilit:
- Treating Intractable Phantom Limb Pain with Ambulatory Continuous Peripheral Nerve Blocks: A Pilot StudyPain Medicine, 2013
- Ultrasound-Guided Continuous Thoracic Paravertebral Block for Outpatient Acute Pain Management of Multilevel Unilateral Rib FracturesAnesthesia & Analgesia, 2013
- Are Mastectomy Rates Really Increasing in the United States?Journal of Clinical Oncology, 2010
- Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendationsPain, 2010
- The accuracy of pain and fatigue items across different reporting periodsPain, 2008
- Thoracic Paravertebral Block for Breast Cancer Surgery: A Randomized Double-Blind StudyAnesthesia & Analgesia, 2007
- Fentanyl and clonidine as adjunctive analgesics with levobupivacaine in paravertebral analgesia for breast surgeryAnaesthesia, 2006
- Single-Injection Paravertebral Block Before General Anesthesia Enhances Analgesia After Breast Cancer Surgery With and Without Associated Lymph Node BiopsyAnesthesia & Analgesia, 2004
- What decline in pain intensity is meaningful to patients with acute pain?Pain, 2003
- Likelihood Ratio Tests for Model Selection and Non-Nested HypothesesEconometrica, 1989